| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.315 | 9.889 | 15.847 | 30.181 | 32.217 | 33.405 | 29.363 | 29.332 | 32.517 |
| Total Income - EUR | - | 2.315 | 15.169 | 25.853 | 30.442 | 33.048 | 33.433 | 29.403 | 29.377 | 32.596 |
| Total Expenses - EUR | - | 1.205 | 12.490 | 25.637 | 18.976 | 23.991 | 28.267 | 33.425 | 36.520 | 33.995 |
| Gross Profit/Loss - EUR | - | 1.110 | 2.679 | 216 | 11.466 | 9.057 | 5.166 | -4.021 | -7.143 | -1.398 |
| Net Profit/Loss - EUR | - | 1.041 | 2.488 | 75 | 11.164 | 8.606 | 4.872 | -4.274 | -7.393 | -1.718 |
| Employees | - | 0 | 2 | 2 | 2 | 1 | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Otisan Medis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 3.945 | 14.887 | 14.447 | 68.473 | 65.893 | 57.837 | 48.045 | 46.500 |
| Current Assets | - | 1.600 | 8.876 | 1.557 | 17.598 | 14.017 | 15.131 | 13.469 | 9.042 | 3.128 |
| Inventories | - | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 672 | 0 |
| Receivables | - | 0 | 2.311 | 917 | 974 | 593 | 621 | 1.109 | 894 | 2.533 |
| Cash | - | 1.584 | 6.566 | 640 | 16.623 | 13.424 | 14.510 | 12.360 | 7.477 | 595 |
| Shareholders Funds | - | 1.085 | 3.555 | 3.565 | 14.659 | 22.988 | 27.349 | 23.160 | 15.697 | 13.892 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 515 | 9.267 | 12.879 | 17.386 | 59.503 | 53.675 | 48.146 | 41.390 | 35.735 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Otisan Medis Srl